Published : 09-10-2023 - Duration : 00:45 - View : 11
Dailymotion : Download MP4 Convert to MP3
Description :
Bristol-Myers Squibb will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion to diversify its oncology portfolio and add drugs to offset losses from upcoming patent expirations. Bristol will pay $58 per share in cash for Mirati, or $4.8 billion. With Mirati's $1.1 billion cash, the enterprise value is $3.7 billion. Mirati sharehold...

Related Videos :
Nils’ Story: A Passion for Discovery and Changing the Way Cancer is Treated | Bristol-Myers Squibb Company |
The 2015 Coast 2 Coast 4 Cancer Ride | Bristol-Myers Squibb Company |
Why Bristol-Myers Squibb Has Cancer Patients and Survivors Talk To Staff |
Go Green: Bristol-Myers Squibb’s Commitment to the Environment | Bristol-Myers Squibb Company |
3. Palme de l'Intelligence Relationnelle - BRISTOL-MYERS SQUIBB |